Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 87,010 shares at $69.86 ($6.0M) on 2020-11-09, disclosed to the SEC on 2020-11-12.
Open-market sale of $6.0M ARWR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.04 | 25,840 | $1.8M | 29.6% |
| 2 | $69.04 | 25,840 | $1.8M | 29.6% |
| 3 | $69.86 | 17,665 | $1.2M | 20.4% |
| 4 | $69.86 | 17,665 | $1.2M | 20.4% |
| Total | $69.37 avg | 87,010 | $6.0M | 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |